vs

Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.

Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $104.1M, roughly 1.5× GRID DYNAMICS HOLDINGS, INC.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -1.4%, a 9.2% gap on every dollar of revenue. On growth, GRID DYNAMICS HOLDINGS, INC. posted the faster year-over-year revenue change (3.7% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 12.0%).

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

GDYN vs NUTX — Head-to-Head

Bigger by revenue
NUTX
NUTX
1.5× larger
NUTX
$151.7M
$104.1M
GDYN
Growing faster (revenue YoY)
GDYN
GDYN
+44.8% gap
GDYN
3.7%
-41.1%
NUTX
Higher net margin
NUTX
NUTX
9.2% more per $
NUTX
7.8%
-1.4%
GDYN
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
12.0%
GDYN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GDYN
GDYN
NUTX
NUTX
Revenue
$104.1M
$151.7M
Net Profit
$-1.5M
$11.8M
Gross Margin
34.8%
30.4%
Operating Margin
61.7%
20.4%
Net Margin
-1.4%
7.8%
Revenue YoY
3.7%
-41.1%
Net Profit YoY
-150.6%
-80.8%
EPS (diluted)
$-0.02
$2.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GDYN
GDYN
NUTX
NUTX
Q1 26
$104.1M
Q4 25
$106.2M
$151.7M
Q3 25
$104.2M
$267.8M
Q2 25
$101.1M
$244.0M
Q1 25
$100.4M
$211.8M
Q4 24
$100.3M
$257.6M
Q3 24
$87.4M
$78.8M
Q2 24
$83.0M
$76.1M
Net Profit
GDYN
GDYN
NUTX
NUTX
Q1 26
$-1.5M
Q4 25
$306.0K
$11.8M
Q3 25
$1.2M
$55.4M
Q2 25
$5.3M
$-17.7M
Q1 25
$2.9M
$21.2M
Q4 24
$4.5M
$61.6M
Q3 24
$4.3M
$-8.8M
Q2 24
$-817.0K
$-364.0K
Gross Margin
GDYN
GDYN
NUTX
NUTX
Q1 26
34.8%
Q4 25
34.0%
30.4%
Q3 25
33.3%
57.8%
Q2 25
34.1%
51.2%
Q1 25
36.8%
55.9%
Q4 24
36.9%
55.0%
Q3 24
37.4%
27.8%
Q2 24
35.6%
29.7%
Operating Margin
GDYN
GDYN
NUTX
NUTX
Q1 26
61.7%
Q4 25
0.5%
20.4%
Q3 25
-0.2%
48.7%
Q2 25
-0.1%
13.8%
Q1 25
-2.0%
38.1%
Q4 24
1.3%
44.4%
Q3 24
2.4%
12.3%
Q2 24
0.0%
7.0%
Net Margin
GDYN
GDYN
NUTX
NUTX
Q1 26
-1.4%
Q4 25
0.3%
7.8%
Q3 25
1.1%
20.7%
Q2 25
5.2%
-7.3%
Q1 25
2.9%
10.0%
Q4 24
4.5%
23.9%
Q3 24
4.9%
-11.2%
Q2 24
-1.0%
-0.5%
EPS (diluted)
GDYN
GDYN
NUTX
NUTX
Q1 26
$-0.02
Q4 25
$0.01
$2.34
Q3 25
$0.01
$7.76
Q2 25
$0.06
$-2.95
Q1 25
$0.03
$3.33
Q4 24
$0.06
$11.56
Q3 24
$0.05
$-1.72
Q2 24
$-0.01
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GDYN
GDYN
NUTX
NUTX
Cash + ST InvestmentsLiquidity on hand
$327.5M
$185.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$530.1M
$329.4M
Total Assets
$605.0M
$918.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GDYN
GDYN
NUTX
NUTX
Q1 26
$327.5M
Q4 25
$342.1M
$185.6M
Q3 25
$338.6M
$166.0M
Q2 25
$336.8M
$96.7M
Q1 25
$325.5M
$84.7M
Q4 24
$334.7M
$40.6M
Q3 24
$231.3M
$46.9M
Q2 24
$256.0M
$40.8M
Stockholders' Equity
GDYN
GDYN
NUTX
NUTX
Q1 26
$530.1M
Q4 25
$542.1M
$329.4M
Q3 25
$537.7M
$317.2M
Q2 25
$532.2M
$235.3M
Q1 25
$517.4M
$176.9M
Q4 24
$517.8M
$132.4M
Q3 24
$400.2M
$60.4M
Q2 24
$388.4M
$62.7M
Total Assets
GDYN
GDYN
NUTX
NUTX
Q1 26
$605.0M
Q4 25
$612.9M
$918.5M
Q3 25
$613.2M
$964.5M
Q2 25
$608.9M
$841.0M
Q1 25
$590.9M
$761.9M
Q4 24
$592.2M
$655.3M
Q3 24
$477.3M
$438.5M
Q2 24
$443.6M
$422.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GDYN
GDYN
NUTX
NUTX
Operating Cash FlowLast quarter
$70.4M
Free Cash FlowOCF − Capex
$69.0M
FCF MarginFCF / Revenue
45.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
5.95×
TTM Free Cash FlowTrailing 4 quarters
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GDYN
GDYN
NUTX
NUTX
Q1 26
Q4 25
$9.9M
$70.4M
Q3 25
$7.0M
$99.5M
Q2 25
$14.4M
$27.3M
Q1 25
$9.4M
$51.0M
Q4 24
$7.1M
$54.0K
Q3 24
$9.2M
$6.8M
Q2 24
$10.7M
$13.3M
Free Cash Flow
GDYN
GDYN
NUTX
NUTX
Q1 26
Q4 25
$6.1M
$69.0M
Q3 25
$2.9M
$99.2M
Q2 25
$10.2M
$26.5M
Q1 25
$6.0M
$50.9M
Q4 24
$4.4M
$-341.0K
Q3 24
$5.9M
$6.2M
Q2 24
$8.0M
$12.7M
FCF Margin
GDYN
GDYN
NUTX
NUTX
Q1 26
Q4 25
5.7%
45.5%
Q3 25
2.8%
37.0%
Q2 25
10.1%
10.9%
Q1 25
6.0%
24.0%
Q4 24
4.4%
-0.1%
Q3 24
6.8%
7.8%
Q2 24
9.7%
16.7%
Capex Intensity
GDYN
GDYN
NUTX
NUTX
Q1 26
Q4 25
3.6%
0.9%
Q3 25
3.9%
0.1%
Q2 25
4.1%
0.3%
Q1 25
3.3%
0.0%
Q4 24
2.6%
0.2%
Q3 24
3.7%
0.8%
Q2 24
3.2%
0.7%
Cash Conversion
GDYN
GDYN
NUTX
NUTX
Q1 26
Q4 25
32.34×
5.95×
Q3 25
5.92×
1.80×
Q2 25
2.73×
Q1 25
3.21×
2.40×
Q4 24
1.56×
0.00×
Q3 24
2.15×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GDYN
GDYN

Segment breakdown not available.

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

Related Comparisons